Search results

With enhanced submicron spatial resolution, speed and contrast, the Micro-Computed Tomography beamline opens a window on the micron-scale 3D structure of a wide range of samples relevant to many areas of science including life sciences, materials engineering, anthropology, palaeontology and geology. MCT will be able to undertake high-speed and high-throughput studies, as well as provide a range of phase-contrast imaging modalities.

The outcome could have significant implications for better monitoring, management and remedial action of groundwater globally.

Research portfolio and future expansion of Australian Centre for Neutron Scattering discussed

Australian Centre for Neutorn Scattering - National Deuteration Facility Advisory Committee meets

ANSTO is responsible for the Little Forest Legacy Site (LFLS) located within the ANSTO Buffer Zone boundary. This site, formerly known as the Little Forest Burial Ground (LFBG), was used by the Australian Atomic Energy Commission (AAEC) during the 1960’s to dispose of waste containing low levels of radioactivity and beryllium oxide (non-radioactive) in a series of shallow trenches. There has been regular monitoring of the site since 1966 and the results have been reported in ANSTO’s environmental monitoring reports.

ANSTO has provided supporting experimental evidence of a highly unusual quantum state, a quantum spin liquid (QSL), in a two-dimensional material.

The International Synchrotron Access Program (ISAP) is administered by the Australian Synchrotron and is designed to assist Australian-based synchrotron users to access overseas synchrotron related facilities.

Molten Salt Reactors (MSRs) are nuclear reactors that use a fluid fuel in the form of very hot fluoride or chloride salt rather than the solid fuel used in most reactors. Since the fuel salt is liquid, it can be both the fuel to produce heat and the coolant to transport the heat to a power plant.

Two startups supported by the nandin Innovation Centre at ANSTO have hit the ground running in 2021 securing major opportunities from state governments to see their businesses thrive.

ANSTO research focuses on an advanced form of cancer treatment under consideration in Australia.

The newly built Medicines Manufacturing Innovation Centre (MMIC), co-located at the Australian Synchrotron at Clayton, was officially opened on Wednesday by the Victorian Deputy Premier and Minister for Medical Research the Hon Ben Carroll.

The 3D structure of a fungal and plant enzyme solves 50-year-old mystery.

Australian clean energy technology company, entX Limited is taking advantage of ANSTO’s unique capacity to generate tailored radioisotope products in the OPAL multi-purpose nuclear reactor to advance a series of innovative projects.